Filing Flows › Dare Bioscience (DARE) › Q1 2026 › vs Q1 2025
Dare Bioscience (DARE) Q1 2026 vs Q1 2025 (year over year)
Dare Bioscience's revenue rose $127K (+500%) from $25K in Q1 2025 to $152K in Q1 2026.
Dare Bioscience, Q1 2026: revenue $152K (+500% year over year), net loss $3.0M, operating cash flow −$5.5M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $152K | $25K | $127K | +500% |
| Net loss | $3.0M | $4.4M | −$1.4M | -31% |
| Costs & expenses | $3.2M | $4.6M | −$1.5M | -32% |
| Operating costs | $3.2M | $4.6M | −$1.5M | -32% |
| Interest & other, net | $1K | −$203K | $204K | — |
| Research & development | $660K | $2.3M | −$1.6M | -71% |
| SG&A | $2.2M | $2.3M | −$61K | -3% |
| Operating cash sources | $6.5M | $6.0M | $507K | +8% |
| Depreciation & amortization | $555K | $176K | $379K | +216% |
| Share-based compensation | $455K | $377K | $78K | +21% |
| Cash used in operations | $5.5M | $5.5M | $50K | +0.9% |
| Net loss absorbed | $3.0M | $4.4M | −$1.4M | -31% |
| Working capital & other | $3.5M | $1.6M | $1.9M | +115% |
Questions
How much did Dare Bioscience's revenue grow year over year in Q1 2026?
Dare Bioscience's revenue rose $127K (+500%) from $25K in Q1 2025 to $152K in Q1 2026.